Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis

Abstract

Background:People with schizophrenia and other psychosis show increased proinflammatory and prooxidative status. However, the few studies that have specifically assessed oxidative and inflammatory markers in early onset psychosis (onset before age 18) have shown contradictory results.Methods:Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines for systematic reviews and meta-analyses were used to conduct a systematic literature search to detect studies comparing inflammatory and oxidative markers in early onset psychosis patients and healthy controls.Results:Seven studies met criteria for the qualitative analysis. Four studies met criteria for meta-analysis, comprising an overall sample of 261 early onset psychosis patients and 246 healthy controls. Six independent meta-analyses were performed for catalase, glutathione, glutathione peroxidase, superoxide dismutase, total antioxidant status, and cell/DNA oxidative damage. No significant differences were found between early onset psychosis patients and controls in any of the parameters assessed. Heterogeneity among studies was high. Qualitative analysis of individual studies showed an association of inflammatory and oxidative markers with clinical, cognitive, and neurobiological outcomes, especially in longitudinal assessments.Conclusions:Despite the lack of significant differences between early onset psychosis patients and controls in the oxidative markers assessed in the meta-analyses, results based on individual studies suggest that greater inflammation and oxidative stress might lead to poorer outcomes in patients with first episodes of early onset psychosis.

Oxidative and nitrosative stress markers in obsessive–compulsive disorder: a systematic review and meta‐analysis

“…(2013) found an increase in blood markers of lipid peroxidation (i.e., MDA and/or TBARS) in SZ, already present in first‐episode psychotic patients . However, in individual studies, 8‐OHdG was found to be increased in patients with non‐remitting schizophrenia although not in adolescents with a first psychotic episode, suggesting its association with a chronic disease course . In depression, Jiménez‐Fernández et al.…”

Role of magnetic resonance spectroscopy in cerebral glutathione quantification for youth mental health: A systematic review

“…The complex nature of psychiatric illness, as well as the difficulty in GSH measurement, leaves a heterogeneous evidence base that makes comparison challenging. Contradictions between studies assessing brain GSH make it difficult to compare brain and blood GSH, where studies assessing blood GSH present consistent findings in perturbation in GSH metabolism for first‐episode psychosis (Fraguas, Díaz‐Caneja, Rodríguez‐Quiroga, & Arango, ), schizophrenia (Ng, Berk, Dean, & Bush, ), bipolar disorder and autism (Gu et al, ).…”

Exposure and response prevention therapy augmented with naltrexone in kleptomania: a controlled case study using galvanic skin response for monitoring

“…There is a considerable lack of diagnostic and/or predictive markers in psychiatry that are valid and easy to use for the transfer into a clinical setting (Venkatasubramanian and Keshavan, 2016). However, within recent years an increasing amount of evidence has been accumulated that inflammatory (Fraguas et al, 2017), genetic (Breitenstein et al, 2015) or neuroimaging biomarkers (e.g. Xia et al, 2018) have discriminative or predictive power, although the associations between markers and treatment response are sometimes counter-intuitive.…”